https://www.cipla.com/sites/default/files/Press-release-Cipla-launches-Cippoint-a-point-of-care-device-for-Non-Communicable-Diseases-infectious-diseases-and-other-health-conditions.pdf

https://www.cipla.com/sites/default/files/Press-Release-Cipla-is-certified-as-Great-Place-to-Work-for-the-fifth-year-in-a-row.pdf Source link

Mumbai, India; February 14, 2023: Cipla Limited has been certified as a Great Place To Work® by the Great Place...

Point-of-Care solution to facilitate clinicians in quick and effective decision making State-of-the-art device offering a wide range of testing parameters...

Cipla & Ethris partner for the development of mRNA-based therapies Mumbai, India and Munich, Germany: December 29, 2022: Cipla Limited...

Mumbai, India & Warren, NJ, USA: November 29, 2022: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to...

Amongst the first pharmaceutical companies in India and Asia to be recognised for adopting advanced fourth industrial revolution technologies to...